Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer Read more about Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer Read more about Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) Read more about Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Read more about Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care Read more about An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care
Adapting and Expanding the Asthma-Educator App Read more about Adapting and Expanding the Asthma-Educator App
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) Read more about Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial. Read more about The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial.
A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy Read more about A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy